-
UTI Healthcare Growth
Equity healthcare
Overview ( as on 13/10/25 )
NAV
₹292.56
Last change
₹-2.33 -0.01%
Fund Size (AUM)
1096.95 Cr
Performance
17.12% (5Y)
Fund Details
UTI Healthcare Growth
as of 13/10/25
AUM
1096.95 Cr
Expense Ratio
2.26 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01695
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Growth | 1.31% | 24.55% | 17.12% |
| BSE Healthcare TR INR | -2.62% | 22.66% | 16.82% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.61% |
Ajanta Pharma Ltd |
5.48% |
Cipla Ltd |
5.48% |
Lupin Ltd |
4.7% |
Procter & Gamble Health Ltd |
3.99% |
Glenmark Pharmaceuticals Ltd |
3.74% |
Dr Reddy's Laboratories Ltd |
3.74% |
Gland Pharma Ltd |
3.62% |
Apollo Hospitals Enterprise Ltd |
3.58% |
Alkem Laboratories Ltd |
3.56% |
Sector Allocation
Healthcare |
98.92% |
Basic Materials |
1.08% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
20.02% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.34% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
18.84% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
18.84% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
17.29% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
17.12% (5Y)
-
